NEVVI Medicare utilization intelligence
or browse by specialty
Medicare · fee-for-service Part B

Infectious Disease — Medicare Part B billing by state

$0.20B
Medicare payments
255
Physician groups
19,592,509
Services

255 physician groups whose primary specialty is Infectious Disease billed $0.20B to Medicare fee-for-service in 2024.

Calendar year 2024 · Medicare fee-for-service Part B

Physician groups whose primary specialty is Infectious Disease, by billing state · CY2024
State Groups Services Beneficiary-episodes Medicare payments Standardized payments ↓ Payments / group Services / group
Florida 58 4,907,395 177,163 $34,739,538 $33,884,695 $598,958 84,610
Illinois 10 1,951,815 81,036 $29,940,672 $29,282,589 $2,994,067 195,182
Virginia 7 1,197,880 24,557 $19,710,919 $19,815,281 $2,815,846 171,126
New Jersey 20 787,573 119,514 $19,308,278 $17,891,303 $965,414 39,379
Texas 38 1,692,701 77,629 $17,311,654 $17,607,815 $455,570 44,545
California 25 534,106 49,231 $14,259,035 $13,842,223 $570,361 21,364
Michigan 13 815,970 34,175 $9,180,928 $8,965,683 $706,225 62,767
Arizona 8 180,962 17,296 $5,318,300 $5,339,952 $664,788 22,620
Georgia 8 1,687,098 20,260 $5,099,020 $5,104,223 $637,378 210,887
Pennsylvania 14 142,668 35,206 $5,133,838 $4,985,606 $366,703 10,191
Missouri 9 210,048 18,749 $4,222,951 $4,410,514 $469,217 23,339
New York 16 99,838 22,271 $4,744,936 $4,403,575 $296,558 6,240
Alabama 5 256,177 15,218 $3,975,908 $4,161,216 $795,182 51,235
Nevada 8 49,536 16,706 $3,388,342 $3,452,856 $423,543 6,192
Iowa 2 81,618 5,473 $3,136,683 $3,160,023 $1,568,342 40,809
Colorado 6 2,796,796 17,426 $3,258,868 $3,149,429 $543,145 466,133
Indiana 1 170,998 1,165 $3,115,860 $3,115,678 $3,115,860 170,998
Ohio 7 38,357 17,041 $2,641,537 $2,750,558 $377,362 5,480
Louisiana 6 26,838 6,833 $1,854,531 $1,898,017 $309,089 4,473
Kansas 2 134,786 5,030 $1,645,424 $1,678,317 $822,712 67,393
Kentucky 3 659,379 8,646 $1,522,834 $1,603,984 $507,611 219,793
Tennessee 5 22,290 8,050 $1,354,916 $1,346,924 $270,983 4,458
Maryland 5 36,880 5,200 $1,124,408 $1,096,632 $224,882 7,376
Delaware 4 29,526 7,233 $983,465 $983,487 $245,866 7,382
Oklahoma 3 364,521 5,721 $862,850 $912,082 $287,617 121,507
Arkansas 2 10,345 4,694 $776,650 $834,231 $388,325 5,172
South Carolina 3 14,519 5,139 $800,673 $826,673 $266,891 4,840
Wisconsin 2 15,351 142 $713,494 $714,388 $356,747 7,676
Hawaii 2 9,230 2,786 $680,688 $670,034 $340,344 4,615
Wyoming 1 424,553 5,224 $652,971 $660,716 $652,971 424,553
New Mexico 2 11,099 2,129 $434,488 $451,045 $217,244 5,550
North Carolina 4 5,909 2,736 $422,829 $444,781 $105,707 1,477
Oregon 1 3,985 105 $418,276 $418,284 $418,276 3,985
Massachusetts 2 4,640 2,144 $355,779 $377,486 $177,890 2,320
Nebraska 1 4,756 2,515 $329,014 $352,198 $329,014 4,756
West Virginia 2 178,241 2,447 $342,951 $329,048 $171,476 89,120
Connecticut 3 3,242 1,672 $242,455 $228,770 $80,818 1,081
Mississippi 2 15,246 277 $188,486 $188,952 $94,243 7,623
Washington 3 5,273 739 $154,575 $152,518 $51,525 1,758
Maine 1 1,400 509 $92,647 $90,070 $92,647 1,400
Minnesota 2 936 326 $81,730 $81,760 $40,865 468
Idaho 1 772 325 $67,614 $73,361 $67,614 772
VI 1 6,761 77 $73,982 $72,394 $73,982 6,761
PR 1 194 79 $13,939 $17,179 $13,939 194
Rhode Island 1 109 100 $13,462 $13,206 $13,462 109
District of Columbia 1 191 120 $13,732 $12,487 $13,732 191
Ranked by standardized payments — the cross-state basis (regional price differences removed). The Medicare payments column shows what Medicare actually paid. Each state opens the ranked Infectious Disease market for that state's biggest code.

Need this specialty's market in one document?

Notify me at launch

Each group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.

All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.

Top codes by Medicare payments CY2024

Code Services Medicare payments ↓ Largest state markets
99232 · Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 684,216 $41,699,051 FLILVANJTX
99233 · Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 382,967 $35,360,746 FLILVANJTX
99223 · Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 136,286 $18,231,998 FLILVANJTX
J0897 · Injection, denosumab, 1 mg 458,942 $9,327,117 FLILVANJTX
99222 · Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 88,751 $9,102,489 FLILVANJTX
99214 · Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more 94,679 $8,798,083 FLILVANJTX
J3245 · Injection, tildrakizumab, 1 mg 79,600 $8,531,156 FLILVANJTX
J3380 · Injection, vedolizumab, intravenous, 1 mg 423,000 $7,314,834 FLILVANJTX
J0875 · Injection, dalbavancin, 5 mg 519,016 $6,239,260 FLILVANJTX
96365 · Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 112,090 $5,447,890 FLILVANJTX
J1306 · Injection, inclisiran, 1 mg top by services 559,732 $5,313,077 FLILVANJTX
J0485 · Injection, belatacept, 1 mg top by services 542,342 $1,612,812 FLILVANJTX
J0878 · Injection, daptomycin, 1 mg top by services 12,019,262 $476,306 FLILVANJTX
J0872 · Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg top by services 664,012 $117,392 FLILVANJTX
J0873 · Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg top by services 411,700 $11,786 FLILVANJTX
Top codes by Medicare payments and by services (both rankings, duplicates merged; capped, never the full code list). “top by services” marks codes here on service volume rather than payments. Each code is searchable free at full depth; state links open that code's ranked market page.

Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.

Notify me at launch